Global and United States Sacral Neuromodulation System Market Report & Forecast 2022-2028

Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities.
Market Analysis and Insights: Global and United States Sacral Neuromodulation System Market
This report focuses on global and United States Sacral Neuromodulation System market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Sacral Neuromodulation System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Internal Neuromodulation System accounting for % of the Sacral Neuromodulation System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Spinal Cord Stimulation was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Sacral Neuromodulation System market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Sacral Neuromodulation System Scope and Market Size
Sacral Neuromodulation System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sacral Neuromodulation System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Sacral Neuromodulation System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Internal Neuromodulation System
External Neuromodulation System
Segment by Application
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)